SHOULD MEDICAL PROFESSIONALS SUPPORT NEW START UPS

In my extensive journey within the pharmaceutical industry, I have witnessed remarkable advancements driven by innovation and collaboration. As a seasoned pharmaceutical specialist deeply engaged in R&D with many of you, I want to address an important perspective on our industry's future.

Often, the trust and confidence we place in well-established pharmaceutical giants can overshadow the incredible potential of small startups. These emerging companies may lack the same recognition, but they are brimming with fresh ideas, agility, and pioneering technologies that can redefine patient care.

Dismissing these startups simply due to their size or relative newness can be a regressive approach. By doing so, we risk stifling the very innovation that propels our industry forward. Smaller pharmaceutical firms frequently operate at the cutting edge, offering unique solutions and specialised expertise that larger entities may overlook.

I encourage you to explore these smaller players and evaluate their systems and procedures. Your engagement and openness can foster a more dynamic, diverse, and progressive pharmaceutical landscape. Together, we can champion new talent, nurture innovation, and ultimately enhance the quality of care we provide to our patients.

Let's keep the spirit of discovery alive and support the growth of all contributors to our field.

Best regards,

Amit Katoch,

JAKSTAR PHARMA

Senior Pharmaceutical Specialist

#PharmaInnovation #SupportStartups #FutureOfMedicine #R&D #HealthcareAdvancement #pcdpharma #pharmapcd #pharma #medicines #pharmafranchis

e